Wntl and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells

EMBO Reports

Volumn 4, Issue 2, 2003, Pages 166-171

  Civenni, Gianluca ^a   Holbro, Thomas ^a   Hynes, Nancy E ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; FRIZZLED PROTEIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ANTIBODY; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; WNT5A PROTEIN; METALLOPROTEINASE; ONCOPROTEIN; WNT PROTEIN; WNT1 PROTEIN; WNT1 PROTEIN, HUMAN; WNT5A PROTEIN, HUMAN; ZEBRAFISH PROTEIN; CGS 27023A; MEMBRANE PROTEIN; PHENANTHROLINE; TRANSCRIPTION FACTOR;

ARTICLE; BREAST EPITHELIUM CELL; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HC11 CELL LINE; HEK293 CELL LINE; LIGAND BINDING; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION; BIOSYNTHESIS; BREAST; CELL LINE; EPITHELIUM; FEMALE; GENETICS; HUMAN; METABOLISM; CULTURE MEDIUM; EPITHELIUM CELL; GENE FUNCTION; GENE INDUCTION; HUMAN CELL; MAMMARY GLAND; ONCOGENE; PROTEIN BINDING; SOLUBILITY;

BREAST; CELL LINE; CYCLIN D1; EPITHELIUM; FEMALE; HUMANS; METALLOENDOPEPTIDASES; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; WNT PROTEINS; WNT1 PROTEIN; ZEBRAFISH PROTEINS;

EID: 0037296518     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.embor.embor735     Document Type: Article

References (33)

1. Badache, A. & Hynes, N.E. (2000) Interleukin 6 inhibits proliferation and, in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells. Cancer Res., 61, 383-391.
2. Bienz, M. (1998) TCF: transcriptional activator or repressor? Curr. Opin. Cell Biol., 10, 366-372.
3. Bienz, M. & Clevers, H. (2000) Linking colorectal cancer to Wnt signalling. Cell, 103, 311-320.
4. Brandt, R., Wong, A.M.L. & Hynes, N.E. (2001) Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic model for testing anti-cancer agents. Oncogene, 20, 5459-5465.
5. Brantjes, H., Roose, J., van de Wetering, M. & Clevers, H. (2001) All Tcf HMG box transcription factors interact with groucho-related co-repressors. Nucleic Acids Res., 29, 1410-1419.
6. Brisken, C. et al. (2000) Essential function of Wnt-4 in mammary gland development downstream of progesterone signalling. Genes Dev., 14, 650-654.
7. Carpenter, G. (1999) Employment of the epidermal growth factor receptor in growth factor-independent signalling pathways. J. Cell Biol., 146, 697-702.
8. Dong, J. et al. (1999) Metalloprotease-mediated ligand release regulates autocrine signalling through the epidermal growth factor receptor. Proc. Natl Acad. Sci. USA, 96, 6235-6240.
9. Gavin, B. & McMahon, A.P. (1992) Differential regulation of the wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol. Cell. Biol., 12, 2418-2423.
10. Gschwind, A., Zwick, E., Prenzel, N., Leserer, M. & Ullrich, A. (2001) Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene, 20, 1594-1600.
11. He, T.C. et al. (1998) Identification of c-Myc as a target of the APC pathway. Science, 281, 1509-1512.
12. Hynes, N. E. et al. (1990) EGF receptor, but not c-erbB2, activation prevents lactogenic hormone induction of the β-casein gene in mouse mammary epithelial cells. Mol. Cell. Biol., 10, 4027-4034.
13. Lane, H.A. et al. (2000) ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency. Mol. Cell. Biol., 20, 3210-3223.
14. Mao, B. et al. (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature, 411, 321-325.
15. Massague, J. & Pandiella, A. (1993) Membrane-anchored growth factors. Annu. Rev. Biochem., 62, 515-541.
16. Neve, R., et al. (2000) Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumor cells. Oncogene, 19, 1647-1656.
17. van Noort, M. & Clevers, H. (2002) TCF transcription factors, mediators of Wnt-signalling in development and cancer. Dev. Biol., 244, 1-8.
18. Nusse, R. (1999) Wnt targets. Repression and activation. Trends Genet., 15, 1-3.
19. Nusse, R. & Varmus, H.E. (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell, 31, 99-109.
20. Olayioye, M.A., Neve, R.M., Lane, H.A. & Hynes, N.E. (2000) The ErbB signalling network: receptor heterodimerization in development and cancer. EMBO J., 19, 3159-3167.
21. Polakis, P. (2000) Wnt signalling and cancer. Genes Dev., 14, 1837-1851.
22. Prenzel, N. et al. (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature, 402, 884-888.
23. Sorensen, B.S., Torring, N., Bor, M.V. & Nexo, E. (2000) Quantitation of the mRNA expression of the EGF system: selective induction of HB-EGF and AR expression by growth factor stimulation of prostate stromal cells. J Lab. Clin. Med., 136, 209-217.
24. Taverna, D., Groner, B. & Hynes, N.E. (1991) EGF receptor, PDGR receptor, and c-erbB2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation. Cell Growth Differ., 2, 145-154.
25. Tetsu, O. & McCormick, F. (1999) Beta-catenin regulates expression of cyclinD1 in colon carcinoma cells. Nature, 398, 422-426.
26. Traxler, P., et al., (2001) Tyrosine kinase inhibitors: from rational design to clinical trials. Med. Res. Rev., 21, 499-512.
27. Troyer, K.L. & Lee, D.C. (2001) Regulation of mouse mammary gland development and tumorigenesis by the ERBB signalling network. J. Mammary Gland Biol. Neoplasia, 6, 7-21.
28. Ugolini, F. et al. (2001) WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas of the medullary type. Oncogene, 20, 5810-5817.
29. Uren, A. et al. (2000) Secreted frizzled-related protein 1 binds directly to wingless and is a biphasic modulator of Wnt signalling. J. Biol. Chem., 275, 4374-4382.
30. van de Wetering, M., et al. (2002) The β-catenin/Tcf-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111, 241-250.
31. Wang, Y., Johnson, A.R., Ye, Q.Z. & Dyer, R.D. (1999) Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain. J. Biol. Chem., 274, 33043-33049.
32. Willert, J., Epping, M., Pollack, J.R., Brown, P.O. & Nusse, R. (2002) A transcriptional response to Wnt proteins in human embryonic carcinoma cells. BMC Dev. Biol., 2, 8-14.
33. Yu, Q., Geng, Y. & Sicinski, P. (2001) Specific protection against breast cancers by cyclin D1 ablation. Nature, 411, 1017-1021.